<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1901210429
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1998
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PONSTAN FORTE 500 mg film-coated tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MEFENAMIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        15.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AG01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Ponstan Forte contains the active ingredient mefenamic acid, a substance which in addition to a pain-relieving effect has marked anti-inflammatory and fever-reducing effects . Ponstan Forte is used to treat:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sudden-onset or persistent pain in rheumatic diseases, muscle pain, pain in the spinal cord area (e.g., Vertebral l discs, shoulder , or neck pain),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain following surgery, injuries, or dental procedures,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; head, tooth, and ear ache,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; painful and/or excessive menstrual bleeding.</p><p>&nbsp;</p><p>Ponstan Forte is also indicated for fever reduction and pain relief in common colds as well as other febrile illnesses, in particular of those in the respiratory system.</p><p>&nbsp;</p><p>Subject to prescription by a doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Ponstan Forte </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to any of the ingredients or if you have experienced shortness of breath or allergy-type skin reactions after taking acetylsalicylic acid or other analgesic or anti-inflammatory drugs, so-called non-steroidal anti-inflammatory drugs (NSAIDs),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in the last trimester of pregnancy,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; while breast-feeding,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have active peptic and/or duodenal ulcers or gastrointestinal bleeding,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have chronic bowel inflammation (Crohn&#39;s disease, ulcerative colitis),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have severe liver or kidney dysfunction,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a severe cardiac output deficiency,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to treat pain after coronary bypass surgery on the heart (in particular when using a heart-lung machine).</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Ponstan Forte.</p><p>&nbsp;</p><p>Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. Patients on prolonged therapy should be kept under regular surveillance with particular attention to liver dysfunction, rash, blood dyscrasias or development of diarrhea. Appearance of any of these symptoms should be regarded as an indication to stop therapy immediately.</p><p>&nbsp;</p><p>During treatment with Ponstan Forte mucosal ulcers as well as mucosal bleeding (in rare cases) and gastrointestinal perforation (in isolated cases) may occur in the upper gastrointestinal tract. These complications may develop at any time during treatment, even without warning signs. In order to reduce this risk, your doctor will prescribe the lowest effective dose for the shortest duration of treatment possible.</p><p>The concomitant ingestion of alcoholic beverages may also increase the risk of side effects in the upper gastrointestinal tract.</p><p>Contact your doctor if you experience persistent diarrhoea, stomach pain and/or if you suspect a connection with the use of this medicine.</p><p>For certain pain-relieving medicines, so-called COX-2 inhibitors, an increased risk for heart attack and stroke was observed at high doses and/or during long-term treatment. Whether this risk also applies to Ponstan Forte is not yet known. If you have suffered from a heart attack, stroke or venous thrombosis in the past, or if you have risk factors (such as high blood pressure, diabetes, high blood lipid values, smoking), your doctor will decide whether you can use Ponstan Forte nevertheless. Inform your doctor about this in any case.</p><p>Using Ponstan &nbsp;Forte can affect the function of your kidneys, which can result in blood pressure increase and/or fluid retention (oedema). Tell your doctor if you suffer from heart or kidney disease, if you are taking medicines to treat high blood pressure (e.g. diuretics, ACE inhibitors), or in case of an increased fluid loss, for example due to profuse sweating.</p><p>&nbsp;</p><p>Severe skin reactions have been reported in connection with the treatment with nonsteroidal antirheumatics. The greatest risk of such reactions seems to exist at the start of treatment. If a skin rash occurs, including fever, lesions of the mucosa, blisters or other signs of an allergy, you should suspend treatment with Ponstan Forte and go for immediate medical treatment as these may be the first signs of a very serious skin reaction (see heading &laquo;Possible side effects&raquo;).</p><p>&nbsp;</p><p>Other NSAIDs, as used to treat pain and arthritis or - such as acetyl salicylic acid - as anti-platelet drug, should not be used concomitantly with Ponstan Forte as they increase the risk of side effects. This also applies to concomitant use of cortisone-containing anti-inflammatory agents, anti-coagulant medicines (anti-clotting medicines) or serotonin reuptake inhibitors, used to treat depression, for example. Please tell your doctor if you are using any of these medicines at the same time as Ponstan Forte. Also tell your doctor if you suffer from asthma, gastrointestinal, liver, cardiovascular or kidney disease, epilepsy, blood-clotting disorders or elevated blood glucose levels or have had these conditions in the past and are taking appropriate medicines.</p><p>&nbsp;</p><p>Stop taking Ponstan Forte and tell your doctor <strong>immediately</strong> if you experience one or several of the following symptoms: allergic reaction with swelling of the face, mouth, tongue or throat, often combined with rash, redness, fewer and/or collapse.</p><p>&nbsp;</p><p>Ponstan Forte film-coated tablets contain less than 1 mmol (23 mg) of sodium, which means they are almost free of sodium.</p><p>&nbsp;</p><p>Due to possible side effects such as drowsiness, fatigue, dizziness or visual disturbances, this medicine may affect your ability to react, to drive or to use tools or machines.</p><p>&nbsp;</p><p>Tell your doctor or pharmacist also if you</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from other illnesses,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have any allergies or</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are using other medicines (including those bought over the counter).</p><p>&nbsp;</p><p><strong>Other medicines and </strong><strong>Ponstan Forte</strong></p><p>Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines. Many medicines interact with each other regarding their mechanism of action and potential adverse effects may occur more frequently or increase in intensity.</p><p>&nbsp;</p><p>This applies in particular to anticoagulants, such as warfarin, Corticosteroids (medicines containing cortisone), lithium and serotonin reuptake inhibitors, i.e. the so-called SSRIs (psychotropic medicines to treat depression), oral antidiabetics (for diabetes), methotrexate (for cancer), cyclosporine and tacrolimus (for dampening the immune system), diuretics (urination medicines) and other high blood pressure medicines, other analgesics, such as Acetylsalicylic acid (for anti-platelet effect).</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>You should not take Ponstan Forte unless absolutely necessary and prescribed by a doctor. If taken during the first 6 months of pregnancy, the dose should be kept as low and the duration of treatment as short as possible.</p><p>Taking nonsteroidal antirheumatics (NSAIDs) from the 20th week of pregnancy onwards may harm your unborn child. If you have to take NSAIDs for more than 2 days, your doctor may need to monitor the volume of amniotic fluid in the womb and the heart of the unborn child.</p><p>&nbsp;</p><p>Ponstan Forte must not be used in the third trimester of pregnancy.</p><p>&nbsp;</p><p>Ponstan Forte should be used with cautions and medical advise during the first and second trimester, you should avoid using Ponstan Forte starting from week 20 of pregnancy.</p><p>&nbsp;</p><p>Ponstan Forte should not be used while breast-feeding.</p><p>&nbsp;</p><p>Tell your doctor if you are pregnant or breast-feeding in any case.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>No studies have been performed on the effects on the ability to drive and operate machines. You should be cautious due to potential adverse side-effects like dizziness and fatigue.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always keep to the dosage prescribed by your doctor</p><p><strong>&nbsp;</strong></p><p>The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.</p><p>&nbsp;</p><p>For Adults and children over 14 years of age:</p><p>1 Ponstan Forte film-coated tablet three times daily, together with food. If necessary, this dose can be reduced or increased. However, you should not take more than 4 film-coated tablets.</p><p>Do not deviate from the prescribed dosage. If you believe that the effect of the medicine is too weak or too strong, talk to your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The following side effects may occur while taking Ponstan Forte:</p><p>&nbsp;</p><p>The most frequently reported side effects associated with mefenamic acid involve the gastrointestinal tract.</p><p>&nbsp;</p><p><strong><em>Common</em></strong><em> (affecting between 1 and 10 patients in every 100)</em></p><p>Diarrhoea, stomach pain, nausea or vomiting.</p><p>&nbsp;</p><p><strong><em>Uncommon</em></strong><em> (affecting between 1 and 10 patients in every 1000)</em></p><p>Loss of appetite, heartburn, wind, constipation, other gastrointestinal disorders, hypersensitivity reactions of the skin (rash, itching), hives and sweating.</p><p>&nbsp;</p><p><strong><em>Rare</em></strong><em> (affecting between 1 and 10 patients in every 10&#39;000)</em></p><p>Swelling of the skin, face and tongue, headache, dizziness, fatigue, drowsiness, insomnia, nervousness, depression, convulsions, palpitations, swelling of the ankles, feet and legs (symptoms of heart weakness), high or low blood pressure, breathing problems, changes in glucose metabolism in diabetic patients, inflammation of the pancreas, ear pain, ringing in the ears (tinnitus), eye irritation, transient loss of colour vision or other visual disturbances.</p><p>&nbsp;</p><p><strong><em>Very rare</em></strong><em> (affecting fewer than 1 out of 10&#39;000 patients)</em></p><p>Severe allergic reactions and skin allergies with blistering. If you notice any initial symptoms of allergic side effects such as breathing problems or skin rash, stop taking Ponstan Forte and contact your doctor.</p><p>Liver (e.g. jaundice) and kidney dysfunction, changes in blood count as well as hypothermia in pediatric patients. Therefore, if Ponstan Forte has to be used long term, it is important to comply with the regular check-up examinations prescribed by your doctor.</p><p>&nbsp;</p><p><strong><em>Frequency not known</em></strong></p><p>Severe skin reactions known as DRESS syndrome and generalized bullous fixed drug eruption (GBFDE) may occur. The symptoms include skin rash, sometimes with formation of brownish patches and blisters, fever, swollen lymph nodes and high eosinophil counts (a form of white blood cells).</p><p>&nbsp;</p><p><strong><em>Investigations</em></strong></p><p>A positive reaction in certain tests for bile in the urine of patients receiving Mefenamic acid has been demonstrated to be due to the presence of the drug and its metabolites and not to the presence of bile.</p><p><strong>&nbsp;</strong></p><p>If you experience throat pain (angina), high fever and possibly, swelling of the lymph nodes in the neck region (a very rarely observed condition) or pain in the upper abdomen and/or black discolouration of the stool, stop taking this medicine and contact your doctor immediately.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, health care provider or pharmacist.</p><p><strong>&nbsp;</strong></p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" align="left" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><ul><li>Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not store above 30&deg;C&nbsp;&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Shelf life: 36 months.</p><p>&nbsp;</p><p>Do not use Ponstan Forte after the expiry date which is stated on the carton after EXP:. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is Mefenamic acid. One film-coated tablet contains 500 mg of mefenamic acid.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are Microcrystalline Cellulose, Maize Starch, Methylcellulose, Sodium Lauryl Sulphate, Colloidal Anhydrous Silica, Magnesium Stearate, Talc, Hypromellose, Titanium Dioxide (E171), Macrogol 6000, Iron Oxide Yellow (E 172), Vanillin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Pale yellow, oval, biconvex, film-coated tablet, debossed with “500” on one side.
Pack size: 20 film-coated tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                December 2023.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي پونستان فورت على المكون النشط حمض الميفيناميك، وهو مادة ذات تأثير مخفف للألم بالإضافة إلى تأثيراتها الملحوظة فيما يتعلق بمقاومة الالتهاب وخفض الحمى. يستخدم پونستان فورت في علاج التالي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم الذي يحدث بشكل مفاجئ أو الألم المستمر المصاحب للأمراض الروماتيزمية، أو ألم العضلات، أو الألم الذي يحدث في منطقة النخاع الشوكي (مثل: الأقراص الفقرية، أو ألم الكتف أو العنق)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم الذي يلي الخضوع لجراحة، أو الإصابات، أو التدخلات المتعلقة بالأسنان،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام الرأس ، والأسنان، والأذنين،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف الطمث المفرط و/أو المؤلم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يوصف پونستان فورت أيضًا لخفض الحمى وتخفيف الألم في نزلات البرد الشائعة بالإضافة إلى الأمراض الحموية الأخرى، خاصة تلك التي تصيب الجهاز التنفسي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يصرف بموجب وصفة طبية من طبيب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال پونستان فورت</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحساسية تجاه أي من المكونات أو إذا كنت قد أصبت بضيق التنفس أو تفاعلات جلدية من نوع تفاعلات الحساسية بعد تناول حمض الأسيتيل ساليسيليك أو غير ذلك من العقاقير المسكنة للألم أو المضادة للالتهاب، والتي تسمى مضادات الالتهاب غير الستيرويدية (NSAIDs)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في آخر ثلاثة أشهر من الحمل،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أثناء الرضاعة الطبيعية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بقرح هضمية نشطة و/أو قرح نشطة في الاثنى عشر أو نزيف معدي معوي،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالتهاب الأمعاء المزمن (مرض كرون، التهاب القولون التقرحي)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بخلل وظيفي شديد في الكبد أو الكلى،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من نقص شديد في النتاج القلبي،</p><p dir="RTL">لعلاج الألم بعد الخضوع لجراحة في القلب لتركيب مجازة لشريان تاجي (خاصة عند استخدام جهاز قلبي-رئوي).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال</strong><strong> </strong><strong>پونستان فورت</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول پونستان فورت</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن تقليل الآثار غير المرغوب فيها إلى أقل ما يمكن عن طريق استخدام أقل جرعة فعالة لأقصر مدة ضرورية للسيطرة على الأعراض. ينبغي وضع المرضى الخاضعين للعلاج المطول تحت الملاحظة المنتظمة مع إيلاء اهتمام خاص للتأكد من عدم ظهور خلل وظيفي كبدي أو طفح جلدي أو اعتلال في الدم أو الإصابة بالإسهال. ينبغي اعتبار ظهور أي من هذه الأعراض علامة على ضرورة إيقاف العلاج فورًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أثناء العلاج باستخدام پونستان فورت، قد تحدث قرح الغشاء المخاطي وكذلك نزيف الغشاء المخاطي (في حالات نادرة) والانثقاب المعدي المعوي (في حالات منفردة) في القناة المعدية المعوية العليا. يمكن أن تحدث هذه المضاعفات في أي وقت أثناء العلاج، حتى دون علامات تحذيرية. ومن أجل تقليل هذا الخطر، سيصف طبيبك أقل جرعة فعالة لأقصر مدة علاج ممكنة.</p><p dir="RTL">قد يؤدي التناول المتزامن للمشروبات الكحولية أيضًا إلى زيادة مخاطر الإصابة بآثار جانبية في القناة المعدية المعوية العليا.</p><p dir="RTL">تواصل مع طبيبك إذا أُصبت بإسهال مستمر، أو ألم في المعدة، أو كليهما أو إذا كنت تشك في وجود صلة بين الأعراض التي تعاني منها واستخدام هذا الدواء أو الأمرين معًا.</p><p dir="RTL">بالنسبة لبعض الأدوية المسكنة للألم، التي تُسمى مثبطات إنزيم سايكلو أوكسجيناز ٢ (COX-2)، لوحظت زيادة في خطر الإصابة بالنوبة القلبية والسكتة الدماغية عند تناول جرعات عالية أو أثناء العلاج طويل الأمد أو عند اجتماع الأمرين معًا. وليس معروفًا بعد ما إذا كان هذا الخطر ينطبق على تناول پونستان فورت أم لا. إذا كنت قد أُصبت بنوبة قلبية، أو سكتة دماغية، أو تجلط وريدي في الماضي أو لديك عوامل خطر (مثل ضغط الدم المرتفع، مرض السكري، ارتفاع قيم الدهون بالدم، التدخين)، فسيقرر طبيبك ما إذا كان يمكنك استخدام پونستان فورت رغم ذلك. وعلى أي حال، أخبر طبيبك عن هذا الأمر.</p><p dir="RTL">يمكن أن يؤثر استخدام پونستان فورت في وظائف كليتيك، وهو ما قد يسبب ارتفاع ضغط الدم أو احتباس السوائل (التورم) أو الأمرين معًا. أخبر طبيبك إذا كنت تعاني من مرض في القلب أو الكلى، أو إذا كنت تتناول أدوية لعلاج ضغط الدم المرتفع (مثل مدرات البول، مثبطات الإنزيم المحول للأنجيوتنسين (ACE))، أو في حالة زيادة فقدان السوائل، على سبيل المثال بسبب العرق الغزير.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أُبلِغ عن حدوث تفاعلات جلدية شديدة مرتبطة بالعلاج بمضادات الالتهاب غير الستيرويدية. ويبدو أن الخطر الأكبر لحدوث مثل هذه التفاعلات يكون موجودًا في بداية العلاج. في حالة الإصابة بطفح جلدي، بما في ذلك الحمى أو آفات الغشاء المخاطي أو البثور أو غيرها من علامات الحساسية، ينبغي لك إيقاف العلاج باستخدام پونستان فورت وتلقي العلاج الطبي العاجل لأن هذه قد تكون العلامات الأولى لتفاعل جلدي شديد الخطورة (انظر عنوان &quot;الأعراض الجانبية&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي عدم استخدام مضادات الالتهاب غير الستيرويدية الأخرى كتلك المستخدمة لعلاج الألم والتهاب المفاصل أو أحد العقاقير المضادة للصفيحات الدموية - مثل حمض أسيتيل ساليسيليك - بالتزامن مع پونستان فورت، نظرًا لأنها تزيد من خطر الإصابة بالآثار الجانبية. ينطبق هذا أيضًا على الاستخدام المتزامن للعوامل المضادة للالتهابات المحتوية على الكورتيزون أو الأدوية المضادة للتجلط (مضادات التخثر) أو مثبطات استرداد السيروتونين المستخدمة لعلاج الاكتئاب على سبيل المثال. يُرجى إخبار طبيبك إذا كنت تستخدم أيًا من هذه الأدوية في نفس الوقت مع پونستان فورت. وأخبر طبيبك أيضًا إذا كنت تعاني من الربو، أو مرض معدي معوي، أو مرض بالكبد، أو مرض قلبي وعائي، أو مرض بالكلى، أو الصرع، أو اضطرابات تخثر الدم، أو ارتفاع مستويات الجلوكوز في الدم، أو إذا كنت قد أُصبت بهذه الحالات في الماضي وتتلقى الأدوية المناسبة لعلاجها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">توقف عن تناول پونستان فورت وأخبر طبيبك <strong>فورًا</strong> إذا أصبت بواحد أو أكثر من الأعراض التالية: تفاعل حساسية مع تورم الوجه أو الفم أو اللسان أو الحلق، وغالبًا ما يكون مصحوبًا بطفح جلدي و/أو احمرار و/أو حمى و/أو هبوط.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحتوي أقراص پونستان فورت المغلفة بطبقة رقيقة على أقل من ١ مليمول (٢٣ ملجم) من الصوديوم، مما يعني أنها خالية تقريبًا من الصوديوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لوجود آثار جانبية ممكنة مثل النعاس، أو الإرهاق، أو الدوار، أو اضطرابات الرؤية، فقد يؤثر هذا الدواء في قدرتك على إبداء ردود الأفعال، أو القيادة، أو استخدام الأدوات أو الآلات.</p><p dir="RTL">أخبر طبيبك أو الصيدلي أيضًا إذا كنت</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعاني من أمراض أخرى،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أو تعاني من أي حالات حساسية،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أو تستخدم أدوية أخرى (بما في ذلك الأدوية التي تُصرف دون وصفة طبية).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول/تستخدم أو تناولت/استخدمت مؤخرًا أو قد تتناول/تستخدم أي أدوية أخرى. فالعديد من الأدوية تتفاعل مع بعضها البعض فيما يتعلق بآلية عملها، وقد تحدث الآثار الضارة الممكنة بوتيرة أكثر تكرارًا أو تزداد شدتها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينطبق هذا بشكل خاص على مضادات التجلط، مثل وارفارين، والستيرويدات القشرية (الأدوية المحتوية على الكورتيزون)، ومثبطات استرداد الليثيوم والسيروتونين، أي ما يسمى بمثبطات استرداد السيروتونين الانتقائية (SSRIs) (أدوية نفسية لعلاج الاكتئاب)، ومضادات مرض السكري التي تؤخذ عن طريق الفم (لعلاج مرض السكري)، والميثوتريكسات (لعلاج السرطان)، وسيكلوسبورين وتاكروليموس (لكبت الجهاز المناعي)، ومدرات البول (أدوية التبول) وأدوية ضغط الدم المرتفع الأخرى، ومسكنات الألم الأخرى، مثل حمض أسيتيل ساليسيليك (لتأثير مضاد للصفيحات الدموية).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي ألا تتناولي پونستان فورت إلا في حالة الضرورة القصوى وعندما يصفه لكِ الطبيب. إذا تم تناوله خلال أول ٦ أشهر من الحمل، ينبغي إبقاء الجرعة منخفضة لأقصى حد ممكن وتقصير مدة العلاج قدر المستطاع.</p><p dir="RTL">قد يؤدي تناول مضادات الالتهاب غير الستيرويدية (NSAIDs) من الأسبوع ٢٠ من الحمل فصاعدًا إلى إلحاق الضرر بجنينكِ. وإذا تعين عليكِ تناول مضادات الالتهاب غير الستيرويدية لأكثر من يومين، فقد يحتاج طبيبكِ إلى مراقبة حجم السائل الأمنيوسي في الرحم وقلب الجنين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب عدم استخدام پونستان فورت خلال آخر ثلاثة أشهر من الحمل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي استخدام پونستان فورت بحذر وبموجب المشورة الطبية خلال أول وثاني ثلاثة أشهر من الحمل، وينبغي أن تتجنبي استخدام پونستان فورت بدءًا من الأسبوع ٢٠ من الحمل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي عدم استخدام پونستان فورت أثناء الرضاعة الطبيعية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبري طبيبكِ إذا كنتِ حاملًا أو تُرضعين رضاعة طبيعية على أي حال.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير پونستان</strong><strong> </strong><strong>فورت</strong><strong> على القيادة واستخدام الآلات</strong></p><p dir="RTL">لم تُجر أي دراسات حول التأثيرات في القدرة على القيادة وتشغيل الآلات. وينبغي أن تتوخى الحذر بسبب الآثار الجانبية الضارة المحتملة مثل الدوخة والإرهاق.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">التزم دائمًا بالجرعة التي وصفها طبيبك</p><p dir="RTL">&nbsp;</p><p dir="RTL">يكون كبار السن معرضين لخطر زائد للإصابة بتبعات خطيرة للتفاعلات الضارة. في حالة اعتبار تناول مضادات الالتهاب غير الستيرويدية أمرًا ضروريًا، ينبغي استخدام أقل جرعة فعالة لأقصر فترة ممكنة. تنبغي مراقبة المريض بانتظام للتأكد من عدم حدوث نزيف معدي معوي أثناء العلاج بمضادات الالتهاب غير الستيرويدية.</p><p>&nbsp;</p><p dir="RTL">للبالغين والأطفال فوق عمر ١٤ عامًا:</p><p dir="RTL">قرص واحد من پونستان فورت مغلف بطبقة رقيقة ثلاث مرات يوميًا، مع الطعام. وإذا لزم الأمر، يمكن تقليل هذه الجرعة أو زيادتها. ولكن، ينبغي ألا تتناول أكثر من ٤ أقراص مغلفة بطبقة رقيقة.</p><p dir="RTL">لا تُخالف الجرعة الموصوفة. إذا كنت تعتقد أن تأثير الدواء أضعف من اللازم أو أقوى من اللازم، فتحدث إلى طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">قد تحدث الآثار الجانبية التالية أثناء تناول پونستان فورت:</p><p dir="RTL">&nbsp;</p><p dir="RTL">تصيب الآثار الجانبية المُبلغ عنها بشكل أكثر تكررًا المرتبطة باستخدام حمض الميفيناميك القناة المعدية المعوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>شائعة</em></strong><em> (تصيب </em><em>مريضًا واحدًا</em><em> إلى</em><em> </em><em>١٠ مرضى </em><em>من كل </em><em>١٠٠ مريض</em><em>)</em></p><p dir="RTL">الإسهال، أو ألم المعدة، أو الغثيان، أو القيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>غير شائعة</em></strong><em> (تصيب </em><em>مريضًا واحدًا</em><em> إلى ١٠ مرضى من كل ١٠٠٠ مريض)</em></p><p dir="RTL">فقدان الشهية، وحرقة المعدة، وغازات البطن، والإمساك، والاضطرابات المعدية المعوية الأخرى، وتفاعلات فرط الحساسية الجلدية (الطفح الجلدي، الحكة)، والشرى، والعرق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>نادرة</em></strong><em> (تصيب </em><em>مريضًا واحدًا</em><em> إلى ١٠ مرضى من كل ١٠٠٠٠ مريض)</em></p><p dir="RTL">تورم الجلد والوجه واللسان، أو الصداع، أو الدوار، أو الإرهاق، أو النعاس، أو الأرق، أو العصبية، أو الاكتئاب، أو التشنجات، أو الخفقان، أو تورم الكاحلين والقدمين والساقين (أعراض ضعف القلب)، أو ضغط الدم المرتفع أو المنخفض، أو مشكلات التنفس، أو تغيرات في أيض الجلوكوز لدى مرضى السكري، أو التهاب البنكرياس، أو ألم الأذن، أو رنين الأذنين (طنين الأذن)، أو تهيج العين، أو فقدان مؤقت للقدرة على رؤية الألوان، أو غير ذلك من اضطرابات الرؤية.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong><em>نادرة جدًا </em></strong><em>(تصيب أقل من مريض واحد من بين كل ١٠٠٠٠ مريض)</em></p><p dir="RTL">تفاعلات حساسية شديدة وحالات حساسية جلدية مصحوبة بظهور بثور. إذا لاحظت أي أعراض أولية للآثار الجانبية للحساسية مثل مشكلات التنفس أو الطفح الجلدي، فتوقف عن تناول پونستان فورت واتصل بطبيبك.</p><p dir="RTL">بالنسبة للمرضى من الأطفال، تتمثل هذه الأعراض في الخلل الوظيفي بالكلى والكبد (مثل اليرقان)، والتغيرات في تعداد الدم، وكذلك انخفاض درجة حرارة الجسم. لذلك، إذا كان يلزم استخدام پونستان فورت على نحو طويل الأمد، فمن المهم الالتزام بالخضوع للفحوصات الطبية المنتظمة التي يصفها طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>ذات معدل تكرار غير معروف</em></strong></p><p dir="RTL">قد تحدث تفاعلات جلدية شديدة تُعرف باسم متلازمة الطفح الدوائي المصحوب بكثرة اليوزينيات والأعراض الجهازية (DRESS) وطفح دوائي فقاعي معمم و ثابت(GBFDE). وتشمل الأعراض الطفح الجلدي، وأحيانًا تشكّل بقع بنية اللون وبثور، والحمى، وتورم الغدد الليمفاوية، وارتفاع تعداد اليوزينيات (أحد أنواع خلايا الدم البيضاء).</p><p dir="RTL"><strong><em>&nbsp;</em></strong></p><p dir="RTL"><strong><em>الفحوصات</em></strong></p><p dir="RTL">تم إثبات أن حدوث تفاعل موجب في اختبارات معينة لوجود السائل الصفراوي في البول في المرضى الذين يتلقون حمض الميفيناميك هو نتيجة لوجود العقار ونواتج أيضه وليس نتيجة لوجود السائل الصفراوي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تعاني من ألم في الحلق (ذبحة)، أو حمى شديدة، أو احتمالية تضخم في الغدد الليمفاوية بمنطقة الرقبة (حالة تظهر في أحيان نادرة للغاية)، أو ألم في الجزء العلوي من البطن أو تغير لون البراز إلى اللون الأسود، بواقع واحدة أو أكثر من هذه الأعراض، فتوقف عن تناول هذا الدواء واتصل بطبيبك على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن ال</strong><strong>أعراض</strong><strong> الجانبية</strong></p><p dir="RTL">إذا أصبت بأي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي. يشمل هذا أي آثار جانبية محتملة غير مدرجة في هذه النشرة. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول السلامة فيما يتعلق بهذا الدواء</p><p dir="RTL">الإبلاغ عن الأعراض الجانبية</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL">المركز الوطني للتيقظ الدوائي</p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>مركز الاتصال الموحد: ۱۹۹۹۹</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/&lrm;&nbsp;&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><em>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</em></p></td></tr></tbody></table></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يخزن پونستان فورت في درجة حرارة لا تزيد عن ٣٠ درجة مئوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">مدة الصلاحية: ٣٦ شهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم پونستان فورت بعد انتهاء تاريخ الصلاحية المكتوب على ملصق الكرتونة أو غلاف شريط الدواء بعد انتهاء تاريخ الصلاحية &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.&nbsp;</p><p dir="RTL">لا تتخلص من أي أدوية عبر مياه الصرف أو في المخلفات المنزلية. بل اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات في حماية البيئة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي حمض الميفيناميك. قرص واحد مغلف بطبقة رقيقة يحتوي على ٥٠٠ ملجم من حمض الميفيناميك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي: الأسوغة المتمثلة في السيليولوز البلوري المكروي، ونشا الذرة، وسيليولوز الميثيل، وكبريتات لوريث الصوديوم، الغروية اللامائية السيليكا ،وثاني أكسيد السيليكون ، وستيارات المغنيسيوم، والتلك، والهيبروميلوزو ماكروجول&nbsp; ٦٠٠٠، ثاني أكسيد التيتانيوم (E 171)، وأكسيد الحديد الأصفر ((E172، إلى جانب الفانيلين.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">أصفر شاحب، بيضاوي، محدب الشكل ومغطى بغشاء وتوجد عليه&nbsp; &quot;500&quot; على جانب واحد.</p><p dir="RTL">حجم العبوة: ٢٠ قرصًا مغلفًا بطبقة رقيقة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg, Germany</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ديسمبر/كانون الأول ٢٠٢۳.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ponstan Forte 500 mg film-coated tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 500 mg Mefenamic acid.
Excipient with known effect: Each film-coated tablet contains 0.2 mg sodium.
For the full list of excipients see Section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute and chronic pain, particularly pain associated with rheumatic disease, muscle pain, pain in the region of the spinal column (intervertebral disc conditions, shoulder/neck syndrome etc.), post-operative pain and pain following injury, as well as headache, toothache and earache (in particular, pain following dental extraction).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Primary dysmenorrhoea.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dysfunctional or intrauterine device (IUD) caused hypermenorrhoea when organic pelvic pathology has been excluded.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ponstan Forte may also be used for simultaneous pain relief and lowering the temperature in flu-like illnesses. In addition, it is suitable for symptomatic treatment of other infectious diseases associated with fever, especially those localized in the upper respiratory tract.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><strong>&nbsp;</strong></p><p>The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.</p><p>&nbsp;</p><p>In general, adults and children over the age of 14 years take 1 tablet (500mg) three times daily, together with food. The dose may be reduced or increased as required. Daily dosage should not exceed 2.0 g (= 4 tablets)</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>For oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to the active ingredient or one of the excipients (see « Composition»). 
-	History of bronchospasm, urticaria or allergy like symptoms after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs. 
-	Third trimester of pregnancy and lactation period (see « Pregnancy/Lactation»). 
-	Active peptic and/or duodenal ulcerations or gastrointestinal bleeding. 
-	Inflammatory bowel diseases like M. Crohn, Colitis ulzerosa. 
-	Severe hepatic impairment (cirrhosis of the liver and ascites). 
-	Severe renal impairment (creatinine clearance < 30 ml/min). 
-	Severe congestive heart failure (NYHA III-IV). 
-	Treatment of postoperative pain following coronary bypass surgery (or use of a heart-lung machine). 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. Patients on prolonged therapy should be kept under regular surveillance with particular attention to liver dysfunction, rash, blood dyscrasias or development of diarrhea. Appearance of any of these symptoms should be regarded as an indication to stop therapy immediately.</p><p>&nbsp;</p><p><u>Gastrointestinal effects</u></p><p>Gastrointestinal inflammations, ulcerations, bleeding or perforations may develop at any time during treatment with non-steroidal anti-inflammatory drugs (NSAIDs), be it COX-2-selective or not, even without warning symptoms or a history of such problems. In order to reduce this risk, the lowest effective dose should be taken for the shortest treatment period possible.</p><p>Patients most at risk of developing these types of GI complications with NSAIDs are the elderly, patients with cardiovascular disease, patients concomitantly taking antiplatelet drugs such as acetylsalicylic acid (refer to &laquo;Contraindications&raquo; and &laquo;Interactions&raquo;), patients ingesting alcohol, or patients with a prior history of gastrointestinal disease, such as ulceration, GI bleeding or inflammatory conditions. Therefore, Ponstan Forte should be used with caution in these patients.</p><p>The concomitant use of mefenamic acid with systemic NSAIDs, including selective COX-2 inhibitors, oral anticoagulants, corticosteroids or selective serotonin reuptake inhibitors (SSRIs) (see &laquo;Interactions&raquo;) should be avoided due to the increased risk for gastrointestinal side effects.</p><p>When persistent diarrhoea GI bleeding or ulceration occurs in patients receiving mefenamic acid, the treatment should be discontinued</p><p>&nbsp;</p><p><u>Cardiovascular effects </u></p><p>&nbsp;</p><p>For certain selective COX-2 inhibitors, placebo-controlled studies have shown an increased risk of thrombotic cardio- and cerebrovascular complications. It is not yet known whether this risk is directly correlated with the COX-1/COX-2 selectivity of the individual NSAID, all NSAIDs may have a similar risk. As no comparable clinical study data are currently available for mefenamic acid at maximum doses and in long-term treatment, a similarly increased risk cannot be ruled out. Until relevant data become available, mefenamic acid should be used only after a careful benefit/risk analysis in patients with established ischaemic heart disease, cerebrovascular disease, peripheral arterial occlusive disease or with significant risk factors (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking). Likewise, in view of this risk, the lowest effective dose should be taken for the shortest treatment period possible.</p><p>&nbsp;</p><p>The relative increase of the cardiovascular (CV) risk appears to be similar in patients with or without CV disease or CV risk factors. However, patients with known CV disease or CV risk factors may be at greater risk in terms of absolute incidence, due to their increased rate at baseline.</p><p>&nbsp;</p><p><u>Renal effects</u></p><p>The renal effects of NSAIDs include fluid retention with oedema and/or hypertension. In patients with impaired cardiac function and other conditions that predispose to fluid retention, mefenamic acid should therefore only be used with caution. Caution is also required in patients concurrently using diuretics or ACE inhibitors or are otherwise at increased risk of hypovolaemia.</p><p>In rare cases, NSAIDs, including mefenamic acid, may cause interstitial nephritis, glomerulitis, papillary necrosis and the nephrotic syndrome. NSAIDs inhibit the synthesis of renal prostaglandin which plays a supportive role in the maintenance of renal perfusion in patients whose renal blood flow and blood volume are decreased. In these patients, administration of an NSAID may precipitate overt renal decompensation, which is typically followed by recovery to pretreatment state upon discontinuation of NSAID therapy. Patients at greatest risk of such a reaction are those with congestive heart failure, hepatic deficiency, nephrotic syndrome, overt renal disease and the elderly. Such patients should be carefully monitored while receiving NSAID therapy.</p><p>&nbsp;</p><p><u>Skin reactions </u></p><p>&nbsp;</p><p>Under treatment with NSAIDs, serious skin reactions, some of them with fatal outcome, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis (Lyell syndrome) drug eruption with eosinophilia and systemic symptoms (DRESS) and generalized bullous fixed drug eruption (GBFDE) have been reported very rarely (see &laquo;Undesirable effects&raquo;). The risk of occurrence of this reaction seems to be greatest at the start of treatment and these reactions are observed in most cases within one month of the start of treatment. Ponstan Forte should be discontinued at the first occurrence of skin rash, changes to the mucosa or any other sign of hypersensitivity reaction.</p><p>&nbsp;</p><p><u>Haematological effects</u></p><p>Mefenamic acid, like other nonsteroidal anti inflammatory drugs, decreases platelet aggregation and prolongs bleeding time. This effect should be kept in mind when bleeding times are determined. Patients suffering from clotting impairment should be carefully monitored.</p><p>During long-term treatment with Ponstan Forte, regular blood counts and renal function tests should be carried out. This applies particularly to patients with pre-existing impairment of renal function and to elderly patients.</p><p>&nbsp;</p><p><u>Additional Remarks</u></p><p>In patients who are known or suspected to be poor CYP2C9 metabolisers based on previous history/experience with other CYP2C9 substrates, mefenamic acid should be administered with caution as they may have abnormally high plasma levels due to reduced metabolic clearance (see &laquo;Pharmacokinetics&raquo;).</p><p>In patients with impaired liver function or epilepsy Ponstan Forte should also be administered with caution.</p><p>&nbsp;</p><p><u>Excipients of particular interest</u></p><p>Patients with rare hereditary problems of galactose intolerance, complete lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>&nbsp;</p><p>This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, i.e. they are almost &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Acetylsalicylic acid </u></p><p>Mefenamic acid interferes with the anti-platelet effect of low-dose acetylsalicylic acid (ASS), and thus may interfere with ASS&rsquo;s prophylactic treatment of cardiovascular disease.</p><p>&nbsp;</p><p><u>Hypoglycemic agents </u></p><p>There have been reports of changes in the effects of oral hypoglycemic agents in the presence of NSAIDs. Therefore, mefenamic acid should be administered with caution in patients receiving insulin or oral hypoglycemic agents.</p><p>&nbsp;</p><p><u>Anticoagulants </u></p><p>Mefenamic acid has been shown to displace warfarin from protein binding sites and may enhance the response to oral anticoagulants. Concomitant use of NSAIDs, including mefenamic acid, with oral anticoagulants increases the risk of GI and non-GI bleeding and should be given with caution. This applies to anticoagulants of the warfarin-type as well as for novel oral anticoagulants (apixaban, dabigatran and, rivaroxaban). Anticoagulation should therefore be monitored in patients taking oral anticoagulants concomitantly with mefenamic acid.</p><p>&nbsp;</p><p><u>Anti-hypertensives including diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II antagonists (AIIA) and beta-blockers </u></p><p>NSAIDs can reduce the efficacy of diuretics and other antihypertensive drugs.</p><p>&nbsp;</p><p>In patients with impaired renal function (e.g. dehydrated patients or elderly patients with compromised renal function), co-administration of ACE inhibitors or AIIAs or diuretics with cyclo-oxygenase inhibitors can increase the deterioration of the renal function, including the possibility of acute renal failure, which is usually reversible. The occurrence of these interactions should be considered in patients taking mefenamic acid concomitantly with such anti-hypertensives.</p><p>&nbsp;</p><p>Therefore, the concomitant administration of these drugs should be done with caution, especially in elderly patients. Patients should be adequately hydrated and the need to monitor the renal function should be assessed in the beginning of the concomitant treatment and periodically thereafter.</p><p>&nbsp;</p><p><u>Cyclosporine</u><u> </u></p><p>Because of their effect on renal prostaglandins, NSAIDS such as mefenamic acid may increase the risk of nephrotoxicity with cyclosporine.</p><p>&nbsp;</p><p><u>Corticosteroids </u></p><p>Increased risk of gastrointestinal ulceration or bleeding.</p><p><em>&nbsp;</em></p><p><u>Lithium </u></p><p>Mefenamic acid has produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. Thus, when mefenamic acid and lithium are administered concurrently, patients should be observed carefully for signs of lithium toxicity.</p><p>&nbsp;</p><p><u>Methotrexate </u></p><p>Caution is advised when methotrexate is administered concurrently with NSAIDs, including mefenamic acid, because NSAID administration may result in increased plasma levels of methotrexate.</p><p>&nbsp;</p><p><u>Selective Serotonin Reuptake Inhibitors (SSRIs)</u></p><p>The concomitant use of NSAIDs, including mefenamic acid, and SSRIs may increase the risk of gastrointestinal bleeding (see &laquo; Warnings and Precautions&raquo;).</p><p>&nbsp;</p><p><u>Tacrolimus </u></p><p>Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</p><p>&nbsp;</p><p><u>Anti-platelet agents</u></p><p>Increased risk of gastrointestinal ulceration or bleeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Inhibition of prostaglandin synthesis may negatively influence pregnancy and/or embryo development. Data from epidemiological studies points to an elevated risk for miscarriage as well as for cardiac deformities and gastroschisis following use of prosta&shy;glandin synthesis inhibitors in early pregnancy. It is supposed that this risk may increase with dose and duration of therapy.</p><p>It has been demonstrated in animals that application of prosta&shy;glandin synthesis inhibitors causes pre- and post-implant loss and embryo-fetal lethality. Moreover, increased incidence of various deformities including cardiovascular deformities, have been observed in animals which received prosta&shy;glandin synthesis inhibitors during organogenesis.</p><p>&nbsp;</p><p>During the first and second trimester of pregnancy Ponstan Forte should be used only if absolutely necessary and <u>particularly avoided after 20 weeks or later of pregnancy. It may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding the baby and possible complications</u>. In case Ponstan Forte is used in women trying to become pregnant, or during the first and second trimester of pregnancy doses should be kept as low and duration of therapy as short as possible. <u>The health care professionals should consider ultrasound monitoring of amniotic fluid if NSAID treatment extends beyond 48 hours and discontinue the NSAID if oligohydramnios is found</u>.</p><p>&nbsp;</p><p><u>Oligohydramnios/neonatal renal insufficiency/constriction of the ductus arteriosus</u></p><p>Taking NSAIDs in the 20th week of pregnancy or later may cause fetal renal function disorders, oligohydramnios and in certain cases neonatal renal insufficiency. These undesirable effects occur on average after days or weeks of treatment, although in rare cases oligohydramnios has already been reported 48 h after the start of NSAID treatment. Oligohydramnios is often, but not always, reversible by cessation of the treatment. Complications of prolonged oligohydramnios may include e.g. contractures of the limbs and retarded maturation of the lungs. After introduction onto the market, invasive procedures such as exchange transfusion or dialysis had to be performed in some cases of limited neonatal renal function.</p><p>&nbsp;</p><p>In addition, a constriction of the ductus arteriosus after treatment in the second trimester has been reported, but was reversed again in most cases after treatment ceased.</p><p>&nbsp;</p><p>Consider ultrasound monitoring of the amniotic fluid and fetus heart if treatment with Ponstan Forte lasts for more than 48 h.</p><p>&nbsp;</p><p>Cease administration of Ponstan Forte if oligohydramnios or constriction of the ductus arteriosus occurs and perform a subsequent examination consistent with clinical practice.</p><p>&nbsp;</p><p>The use of Ponstan Forte is contraindicated in the third trimester of pregnancy. All prosta&shy;glandin synthesis inhibitors may</p><p>- expose the fetus to the following risks:&nbsp;</p><ul><li>Cardio-pulmonary toxicity (connected with the premature closure of the ductus arteriosus and pulmonary arterial hypertension);</li><li>Renal dysfunction that may progress to renal failure with oligohydramniosis.</li></ul><p>- expose mother and child to the following risks:</p><ul><li>Potential prolongation of bleeding time, this thrombocyte aggregation inhibiting effect might even occur at very low doses;</li></ul><ul><li>Inhibition of uterus contractions with the consequence of late onset of or prolonged labour.</li></ul><p>&nbsp;</p><p><u>Lactation</u></p><p>Because mefenamic acid passes into breast milk with associated possible adverse effects on the child, nursing mothers should not use Ponstan Forte.</p><p><strong>&nbsp;</strong></p><p><strong>Fertility</strong></p><p>The use of mefenamic acid may influence female fertility, and is therefore not recommended in women wishing to become pregnant. Women with difficulties in becoming pregnant or those undergoing infertility check-ups the discontinuation of mefenamic acid should be considered.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The effect of mefenamic acid on the ability to drive or use machinery has not been systematically evaluated. Due to potential adverse side-effects like dizziness and fatigue caution is generally advised.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Side effects are classified according to organ class and incidence, and are defined as follows: &laquo;very common&raquo; (&ge;1/10); &laquo;common&raquo; (&ge;1/100, &lt;1/10); &laquo;uncommon&raquo; (&ge;1/1000, &lt;1/100); &laquo;rare&raquo; (&ge;1/10&#39;000, &lt;1/1000); &laquo;very rare&raquo; (&le;1/10&#39;000); &laquo;not known&raquo;: spontaneous reporting from post-marketing surveillance.</p><p><u>&nbsp;</u></p><p><u>Blood and lymphatic system disorders</u></p><p><strong>Very rare:</strong> Changes in blood counts (leucopenia, autoimmune haemolytic anaemia, aplastic anaemia, agranulocytosis, purpura, eosinophilia, thrombocytopenia, pancytopenia, bone marrow aplasia, decreased hematocrit).</p><p><strong>Not known:</strong> Platelet aggregation inhibition.</p><p>&nbsp;</p><p><u>Immune system disorders</u></p><p><strong>Rare:</strong> Allergic manifestations such as allergic oedema, bronchospasm and anaphylactic reactions, see also SOC &laquo;Skin and subcutaneous tissue disorders&raquo;.</p><p>&nbsp;</p><p><u>Metabolism and nutrition disorders</u></p><p><strong>Rare:</strong><em> </em>Glucose intolerance in diabetic patients, hyponatremia.</p><p>&nbsp;</p><p><u>Nervous system disorders</u></p><p><strong>Rare:</strong> Headaches, drowsiness, dizziness, fatigue, nervousness, depression, insomnia, convulsions, aseptic meningitis.</p><p>&nbsp;</p><p><u>Eye disorders</u></p><p><strong>Rare:</strong> Visual disturbances (blurred vision), eye irritations, reversible loss of color vision.</p><p>&nbsp;</p><p><u>Ear and labyrinth disorders</u></p><p><strong>Rare:</strong> Ear pain, tinnitus.</p><p>&nbsp;</p><p><u>Cardiac disorders</u></p><p><strong>Rare:</strong> Palpitations, heart failure.</p><p>&nbsp;</p><p><u>Vascular disorders</u></p><p><strong>Rare:</strong> Hypotension, hypertension.</p><p>&nbsp;</p><p><u>Respiratory, thoracic and mediastinal disorders</u></p><p><strong>Rare:</strong> Dyspnea, asthma.</p><p>&nbsp;</p><p><u>Gastrointestinal disorders</u></p><p>The most frequently reported side effects associated with mefenamic acid involve the gastrointestinal tract.</p><p><strong>Common:</strong> Diarrhoea, abdominal pain, nausea, vomiting.</p><p><strong>Uncommon:</strong> Anorexia, colitis, constipation, enterocolitis, flatulence, gastrointestinal ulceration (with or without haemorrhage and perforation in isolated cases), pyrosis.</p><p><strong>Rare:</strong> Pancreatitis, steatorrhoea.</p><p><strong>Not known:</strong> Gastrointestinal inflammation.</p><p>&nbsp;</p><p><u>Hepatobiliary disorders</u></p><p><strong>Rare:</strong> Jaundice, hepatitis, hepatorenal syndrome, moderate hepatoxicity, hepatic dysfuntion.</p><p>&nbsp;</p><p><u>Skin and subcutaneous tissue disorders</u></p><p><strong>Uncommon:</strong> Perspiration, urticaria, pruritus, rash.</p><p><strong>Rare:</strong> Angioedema, larynx edema, facial edema.</p><p>Very rare: Stevens-Johnson syndrome, Lyell&rsquo;s syndrome (toxic epidermal necrolysis), erythema multiforme.</p><p><strong>Not known:</strong> Dermatitis exfoliative., drug eruption with eosinophilia and systemic symptoms (DRESS), generalized bullous fixed drug eruption (GBFDE).</p><p>&nbsp;</p><p><u>Renal and urinary tract disorders</u></p><p><strong>Very rare:</strong> Dysuria, renal failure including papillary necrosis, acute interstitial nephritis with hematuria and/or proteinuria, renal dysfunction, sodium and fluid retention.</p><p><strong>Not known:</strong> Glomerulonephritis, nephrotic syndrome.</p><p>&nbsp;</p><p><u>Investigations</u></p><p>Determination of urobilinogen in the urine using the azo method may give false positive results after a dose of mefenamic acid.</p><p>&nbsp;</p><p><u>General disorders</u></p><p><strong>Not known:</strong> Hypothermia (in pediatric patients).</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local country requirements.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong>&nbsp;</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call Center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other </strong><strong>GCC</strong><strong> States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Signs and symptoms</u></p><p>Seizures, acute renal failure, coma, confusional state, vertigo, and hallucination have been reported with mefenamic acid overdoses. Overdose has led to fatalities.</p><p><u>&nbsp;</u></p><p><u>Treatment: </u></p><p>Patients should be managed by symptomatic and supportive care following a mefenamic acid overdose. There are no specific antidotes. Following acute overdosage, induced emesis, and/or gastric lavage, and/or administration of activated charcoal may be considered dependent upon amount ingested and time since ingestion. Vital functions should be monitored and supported.</p><p>&nbsp;</p><p>Haemodialysis is of little value since mefenamic acid and its metabolites are firmly bound to plasma proteins.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Anti-inflammatory and anti- rheumatic products, non-steroids, fenamates<strong><u> </u></strong>ATC-Code: M01AG01</p><p><strong>&nbsp;</strong></p><p>Mechanism of action</p><p>Ponstan Forte contains the active ingredient mefenamic acid, a non-steroidal anti-inflammatory drug, which has anti-inflammatory and antipyretic effects in addition to its analgesic properties. Mefenamic acid acts mainly through the inhibition of prostaglandin synthesis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Mefenamic acid is rapidly absorbed following an oral dose. Absorption is more than 70%. Peak plasma concentrations are measured 1-3 h after administration. The course of the plasma concentration shows linearity with the dose.</p><p>&nbsp;</p><p><u>Distribution </u></p><p>Mefenamic acid is more than 90% bound to plasma proteins and is able to cross the placental barrier. Less than 1% of the serum concentration is found in breast milk.</p><p><em>&nbsp;</em></p><p><u>Metabolism </u></p><p>Mefenamic acid metabolism is predominantly mediated via cytochrome P450 CYP 2C9 in the liver.&nbsp; Patients who are known or suspected to be poor CYP2C9 metabolizers based on previous history/experience with other CYP2C9 substrates should be administered mefenamic acid with caution as they may have abnormally high plasma levels due to reduced metabolic clearance.</p><p><strong>&nbsp;</strong></p><p>The substance undergoes intensive biotransformation. The main metabolites are the 3‑hydroxymethyl and the 3-carboxyl derivatives. Both these metabolites are partially conjugated to glucuronides and show only weak analgesic and anti-inflammatory effects.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>The plasma half-life is about 2 h. Excretion of the mefenamic acid metabolites is primarily in the urine. The proportion of free mefenamic acid in the urine is less than 5%.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Mutagenicity</u></p><p>Mefenamic acid was not extensively investigated with regard to mutagenicity. Hitherto studies were negative.</p><p><em>&nbsp;</em></p><p><u>Carcinogenicity</u><em> </em></p><p>Long-term studies in animals of a tumorigenic potential are not available.</p><p>&nbsp;</p><p><u>Reproductive and developmental toxicity</u></p><p>Animal experiments showed no evidence of teratogenic properties. Mefenamic acid penetrates the placenta and reaches in the plasma of monkey fetuses comparable values as in the plasma of the mother. Because of the mechanism of action, there may be an inhibition of labor, premature closure of the ductus arteriosus Botalli (in particular upon exposure after the 33<sup>rd</sup> week of pregnancy) and an increased bleeding tendency in mother and child. Theoretically, there is the possibility of renal dysfunction of the fetus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline Cellulose, Maize Starch, Methylcellulose, Sodium Lauryl Sulphate, Colloidal Anhydrous Silica, Magnesium Stearate, Talc, Titanium Dioxide (E171), Hypromellose, Macrogol 6000, Iron Oxide Yellow (E 172), and Vanillin</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Do not use Ponstan forte  after the expiry date which is stated on the carton after EXP:. The expiry date refers to the last day of that month.

Shelf life 36 months.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pale yellow, oval, biconvex, film-coated tablet, debossed with &ldquo;500&rdquo; on one side.</p><p>Pack size: 20 Film-coated tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorization holder and Manufactuer:
Pfizer Manufacturing Deutshland GmbH, Betriebsstatte Freiburg, Germany

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December 2023.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>